Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Freitas

Showing results (591-600 of 639) with videos related to

Pageof 64
Sort By:
Cytokine|February 12, 2023
Exploring drug repositioning for leishmaniasis treatment: Ivermectin plus polymeric micelles induce immunological response and protection against tegumentary leishmaniasisCamila S Freitas, Daniela P Lage, Amanda S Machado, et al.
Ambio|October 10, 2021
Biogeochemical consequences of a changing Arctic shelf seafloor ecosystemChristian März, Felipe S Freitas, Johan C Faust, et al.
Vaccines|June 13, 2020
Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral LeishmaniasisDaniela P Lage, Patrícia A F Ribeiro, Daniel S Dias, et al.
Plants (Basel, Switzerland)|October 27, 2022
Integrated Omic Approaches Reveal Molecular Mechanisms of Tolerance during Soybean and <i>Meloidogyne incognita</i> InteractionsFabricio B M Arraes, Daniel D N Vasquez, Muhammed Tahir, et al.
The Journal of Urology|June 20, 2025
Can Genomic Classifiers in Biopsy Cores With Grade Group 1 Cancer Predict Higher-Grade Disease Elsewhere in the Prostate? Results From the Prospective Miami Active Surveillance TrialPedro F S Freitas, Archan Khandekar, Joao G Porto, et al.
Experimental Parasitology|December 18, 2020
Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasisThiago A R Reis, João A Oliveira-da-Silva, Grasiele S V Tavares, et al.
Parasitology Research|September 28, 2023
Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasisMarcelo M Jesus, Daniela P Lage, Danniele L Vale, et al.
Acta Tropica|March 20, 2022
A recombinant Leishmania amastigote-specific protein, rLiHyG, with adjuvants, protects against infection with Leishmania infantumAmanda S Machado, Daniela P Lage, Danniele L Vale, et al.
Parasite Immunology|April 19, 2022
Leishmania LiHyC protein is immunogenic and induces protection against visceral leishmaniasisAmanda S Machado, Daniela P Lage, Danniele L Vale, et al.
Tuberculosis (Edinburgh, Scotland)|April 7, 2024
Serodiagnosis of paucibacillary and multibacillary leprosy using a recombinant chimeric protein composed of specific B-cell epitopes derived from Mycobacterium leprae proteinsBárbara P N Assis, Ana T Chaves, Daniela P Lage, et al.
Pageof 64

Showing results (591-600 of 639) with videos related to

Sort By:
Pageof 64
Cytokine|February 12, 2023
Exploring drug repositioning for leishmaniasis treatment: Ivermectin plus polymeric micelles induce immunological response and protection against tegumentary leishmaniasisCamila S Freitas, Daniela P Lage, Amanda S Machado, et al.
Ambio|October 10, 2021
Biogeochemical consequences of a changing Arctic shelf seafloor ecosystemChristian März, Felipe S Freitas, Johan C Faust, et al.
Vaccines|June 13, 2020
Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral LeishmaniasisDaniela P Lage, Patrícia A F Ribeiro, Daniel S Dias, et al.
Plants (Basel, Switzerland)|October 27, 2022
Integrated Omic Approaches Reveal Molecular Mechanisms of Tolerance during Soybean and <i>Meloidogyne incognita</i> InteractionsFabricio B M Arraes, Daniel D N Vasquez, Muhammed Tahir, et al.
The Journal of Urology|June 20, 2025
Can Genomic Classifiers in Biopsy Cores With Grade Group 1 Cancer Predict Higher-Grade Disease Elsewhere in the Prostate? Results From the Prospective Miami Active Surveillance TrialPedro F S Freitas, Archan Khandekar, Joao G Porto, et al.
Experimental Parasitology|December 18, 2020
Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasisThiago A R Reis, João A Oliveira-da-Silva, Grasiele S V Tavares, et al.
Parasitology Research|September 28, 2023
Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasisMarcelo M Jesus, Daniela P Lage, Danniele L Vale, et al.
Acta Tropica|March 20, 2022
A recombinant Leishmania amastigote-specific protein, rLiHyG, with adjuvants, protects against infection with Leishmania infantumAmanda S Machado, Daniela P Lage, Danniele L Vale, et al.
Parasite Immunology|April 19, 2022
Leishmania LiHyC protein is immunogenic and induces protection against visceral leishmaniasisAmanda S Machado, Daniela P Lage, Danniele L Vale, et al.
Tuberculosis (Edinburgh, Scotland)|April 7, 2024
Serodiagnosis of paucibacillary and multibacillary leprosy using a recombinant chimeric protein composed of specific B-cell epitopes derived from Mycobacterium leprae proteinsBárbara P N Assis, Ana T Chaves, Daniela P Lage, et al.
Pageof 64